Inventor · disambiguated record
Jeffrey L. Edelman
Also filed as: EDELMAN JEFFREY · EDELMAN JEFFREY L
22 granted patents·10 pending applications·228 citations·filing 2004–2021
95Inventor score
Top patents by PatentIndex Score
32 records- 0198US8512738B2Biodegradable intravitreal tyrosine kinase implantsEDELMAN JEFFREY L·Filed 2005·Granted Aug 20, 2013·89 cites·6 claims
- 0294US8968766B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2013·Granted Mar 3, 2015·19 cites·8 claims
- 0394US7771742B2Sustained release intraocular implants containing tyrosine kinase inhibitors and related methodsALLERGAN INC·Filed 2004·Granted Aug 10, 2010·47 cites·15 claims
- 0493US8062657B2Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissuesEDELMAN JEFFREY L·Filed 2006·Granted Nov 22, 2011·30 cites·20 claims
- 0592US9233070B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2013·Granted Jan 12, 2016·6 cites·5 claims
- 0687US10076492B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2016·Granted Sep 18, 2018·4 cites·4 claims
- 0785US10881608B2Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2018·Granted Jan 5, 2021·1 cites·7 claims
- 0885US8906892B24-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2012·Granted Dec 9, 2014·5 cites·15 claims
- 0984US8840872B2Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissuesEDELMAN JEFFREY L·Filed 2011·Granted Sep 23, 2014·6 cites·27 claims
- 1082US9433631B24-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2014·Granted Sep 6, 2016·3 cites·12 claims
- 1182US8865691B2Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2012·Granted Oct 21, 2014·4 cites·12 claims
- 1281US9259429B2Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissuesALLERGAN INC·Filed 2014·Granted Feb 16, 2016·3 cites·17 claims
- 1381US7749530B2Kinase inhibitorsALLERGAN INC·Filed 2008·Granted Jul 6, 2010·5 cites·31 claims
- 1477US10188665B2Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissuesALLERGAN INC·Filed 2017·Granted Jan 29, 2019·1 cites·12 claims
- 1576US8455656B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Jun 4, 2013·2 cites·2 claims
- 1674US9820995B2Ocular therapy using glucocorticoid derivatives selectively penetrating posterior segment tissuesALLERGAN INC·Filed 2016·Granted Nov 21, 2017·1 cites·8 claims
- 1774US9717743B2Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2014·Granted Aug 1, 2017·1 cites·51 claims
- 1873US8143410B2Kinase inhibitorsSPADA LON T·Filed 2009·Granted Mar 27, 2012·1 cites·28 claims
- 1973US2021121397A1Biodegradable intravitreal tyrosine kinase implantsALLERGAN INC·Filed 2021·Application pending·0 cites
- 2069US2009082321A1Steroid containing drug delivery systemsALLERGAN INC·Filed 2007·Application pending·0 cites
- 2167US2019365786A1Pharmaceutical compositions and methods of use of 4-pregenen-11beta-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2018·Application pending·0 cites
- 2264US10493082B24-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2016·Granted Dec 3, 2019·0 cites·1 claims
- 2363US10188667B2Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivativesALLERGAN INC·Filed 2017·Granted Jan 29, 2019·0 cites·24 claims
- 2458US2011077229A1Steroid Containing Drug Delivery SystemsALLERGAN INC·Filed 2010·Application pending·0 cites
- 2553US8383825B2Kinase inhibitorsALLERGAN INC·Filed 2011·Granted Feb 26, 2013·0 cites·30 claims
- 2653US2007059336A1Anti-angiogenic sustained release intraocular implants and related methodsALLERGAN INC·Filed 2006·Application pending·0 cites
- 2752US2012207810A1Kinase InhibitorsSPADA LON T·Filed 2012·Application pending·0 cites
- 2851US2013267497A1Kinase inhibitorsALLERGAN INC·Filed 2013·Application pending·0 cites
- 2950US2005281861A1Macromolecule-containing sustained release intraocular implants and related methodsALLERGAN INC·Filed 2005·Application pending·0 cites
- 3047US2015265633A1Steroid containing drug delivery systemALLERGAN INC·Filed 2015·Application pending·0 cites
- 3146US2006182783A1Sustained release intraocular drug delivery systemsALLERGAN INC·Filed 2006·Application pending·0 cites
- 3241US8969583B23-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitorsALLERGAN INC·Filed 2012·Granted Mar 3, 2015·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Jeffrey L. Edelman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →